The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Unlike traditional microscopes that use light or lenses, DNA microscopy creates images by calculating interactions among ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, ...

Listed below are links to the GEN stories reference in this episode of Touching Base Gene Therapy Tested in Mice Offers New ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Study found that reduced neurotensin in obese mice prevented dopamine from triggering the usual pleasure response to ...

Setting the right priorities and having an overarching leadership structure was key to the successful scale-up of an advanced ...

Model allowed researchers to better understand the complex molecular mechanisms that determine the robustness, flexibility, ...